| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new red cell shape helps the clot
|
Ariëns, Robert A.S.
|
|
|
123 |
10 |
p. 1442-1443
|
artikel
|
| 2 |
A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma
|
Richardson, Paul G.
|
|
|
123 |
10 |
p. 1461-1469
|
artikel
|
| 3 |
A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in β-thalassemia major (CORDELIA)
|
Pennell, Dudley J.
|
|
|
123 |
10 |
p. 1447-1454
|
artikel
|
| 4 |
Bad liver and a broken heart
|
Coates, Thomas D.
|
|
|
123 |
10 |
p. 1434-1436
|
artikel
|
| 5 |
B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)–infected patients rarely react with the viral proteins
|
Ng, Patrick P.
|
|
|
123 |
10 |
p. 1512-1515
|
artikel
|
| 6 |
BuMPing iron with modified heparins
|
Babitt, Jodie L.
|
|
|
123 |
10 |
p. 1440-1441
|
artikel
|
| 7 |
Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study
|
Conter, Valentino
|
|
|
123 |
10 |
p. 1470-1478
|
artikel
|
| 8 |
Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin
|
Cines, Douglas B.
|
|
|
123 |
10 |
p. 1596-1603
|
artikel
|
| 9 |
Disseminated histoplasmosis in peripheral blood smear
|
Park, Haeseong
|
|
|
123 |
10 |
p. 1445
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
123 |
10 |
p. i
|
artikel
|
| 11 |
Epstein-Barr virus–associated lymphocytosis masquerading as lymphoma
|
McCash, Samuel I.
|
|
|
123 |
10 |
p. 1444
|
artikel
|
| 12 |
Fang C, Stavrou E, Schmaier AA, et al. Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2 −/− mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation. Blood. 2013;121(15):3023-3032.
|
|
|
|
123 |
10 |
p. 1622
|
artikel
|
| 13 |
Functional platelet defects in children with severe chronic ITP as tested with 2 novel assays applicable for low platelet counts
|
van Bladel, Esther R.
|
|
|
123 |
10 |
p. 1556-1563
|
artikel
|
| 14 |
Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo
|
Poli, Maura
|
|
|
123 |
10 |
p. 1564-1573
|
artikel
|
| 15 |
How will B-cell-receptor–targeted therapies change future CLL therapy?
|
Jones, Jeffrey A.
|
|
|
123 |
10 |
p. 1455-1460
|
artikel
|
| 16 |
Immune evasion by oncogenic proteins of acute myeloid leukemia
|
Elias, Shlomo
|
|
|
123 |
10 |
p. 1535-1543
|
artikel
|
| 17 |
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia
|
Rotunno, Giada
|
|
|
123 |
10 |
p. 1552-1555
|
artikel
|
| 18 |
Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD
|
Lin, Kaifeng Lisa
|
|
|
123 |
10 |
p. 1604-1614
|
artikel
|
| 19 |
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
|
Rumi, Elisa
|
|
|
123 |
10 |
p. 1544-1551
|
artikel
|
| 20 |
Kumar S, Fonseca R, Ketterling RP, et al. Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics. Blood. 2012;119(9):2100-2105.
|
|
|
|
123 |
10 |
p. 1621
|
artikel
|
| 21 |
Landgren O, Korde N. Treating myeloma: the future is already here! Blood. 2012;120(9):1754-1756.
|
|
|
|
123 |
10 |
p. 1621
|
artikel
|
| 22 |
LECT2 makes the amyloid list
|
Comenzo, Raymond L.
|
|
|
123 |
10 |
p. 1436-1437
|
artikel
|
| 23 |
Leukocyte cell-derived chemotaxin 2 (LECT2)–associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States
|
Mereuta, Oana M.
|
|
|
123 |
10 |
p. 1479-1482
|
artikel
|
| 24 |
MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma
|
Ito, Mitsugu
|
|
|
123 |
10 |
p. 1499-1511
|
artikel
|
| 25 |
Moncada-Vélez M, Martinez-Barricarte R, Bogunovic D, et al. Partial IFN-γR2 deficiency is due to protein misfolding and can be rescued by inhibitors of glycosylation. Blood. 2013;122(14):2390-2401.
|
|
|
|
123 |
10 |
p. 1622
|
artikel
|
| 26 |
Mutations in Krüppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression
|
Viprakasit, Vip
|
|
|
123 |
10 |
p. 1586-1595
|
artikel
|
| 27 |
Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma
|
Li, Hongxiu
|
|
|
123 |
10 |
p. 1487-1498
|
artikel
|
| 28 |
New signaling pathways for hepcidin regulation
|
Arosio, Paolo
|
|
|
123 |
10 |
p. 1433-1434
|
artikel
|
| 29 |
Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations
|
Traer, Elie
|
|
|
123 |
10 |
p. 1516-1524
|
artikel
|
| 30 |
Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation
|
Boulad, Farid
|
|
|
123 |
10 |
p. 1483-1486
|
artikel
|
| 31 |
The (miR)e of CTCL
|
Mishra, Anjali
|
|
|
123 |
10 |
p. 1438
|
artikel
|
| 32 |
Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens
|
Bitan, Menachem
|
|
|
123 |
10 |
p. 1615-1620
|
artikel
|
| 33 |
TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo
|
Ma, Hayley
|
|
|
123 |
10 |
p. 1525-1534
|
artikel
|
| 34 |
Two faces of ET: CALR and JAK2
|
Chao, Mark P.
|
|
|
123 |
10 |
p. 1438-1440
|
artikel
|
| 35 |
Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling
|
Mleczko-Sanecka, Katarzyna
|
|
|
123 |
10 |
p. 1574-1585
|
artikel
|
Tijdschrift beschrijving